Profile
Sector:
HealthcareIndustry:
Healthcare PlansCountry:
United StatesIPO:
31 December 1981Website:
http://www.humana.comNext earnings report:
31 July 2024Last dividends:
28 June 2024Next dividends:
N/APrice
after hours | Wed, 03 Jul 2024 20:52:57 GMTAnalysts recommendations
Institutional Ownership
Included in screeners
HUM Latest News
NEW YORK, NY / ACCESSWIRE / July 4, 2024 / If you suffered a loss on your Humana Inc. (NYSE:HUM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/humana-lawsuit-submission-form?prid=89225&wire=1 or contact Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / July 4, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Humana Inc. ("Humana" or "the Company") (NYSE:HUM) and certain of its officers. Class Definition: This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Humana securities between July 27, 2022 and January 24, 2024, inclusive (the "Class Period").
NEW YORK, NY / ACCESSWIRE / July 4, 2024 / If you suffered a loss on your Humana Inc. (NYSE:HUM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/humana-lawsuit-submission-form?prid=89183&wire=1 or contact Joseph E. Levi, Esq.
LOS ANGELES, CA / ACCESSWIRE / July 4, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Humana Inc. ("Humana" or "the Company") (NYSE:HUM) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between July 27, 2022 and January 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before August 2, 2024.
NEW YORK, NY / ACCESSWIRE / July 4, 2024 / If you suffered a loss on your Humana Inc. (NYSE:HUM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/humana-lawsuit-submission-form?prid=89160&wire=1 or contact Joseph E. Levi, Esq.
NEW YORK , July 4, 2024 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Humana Inc. (NYSE: HUM) between July 27, 2022 and January 24, 2024, both dates inclusive (the "Class Period"), of the important August 2, 2024 lead plaintiff deadline. So what: If you purchased Humana common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
NEW YORK, NY / ACCESSWIRE / July 3, 2024 / If you suffered a loss on your Humana Inc. (NYSE:HUM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/humana-lawsuit-submission-form?prid=89053&wire=1 or contact Joseph E. Levi, Esq.
LOS ANGELES, July 03, 2024 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming August 2, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Humana Inc. (“Humana” or the “Company”) (NYSE: HUM) common stock between July 27, 2022 and January 24, 2024, inclusive (the “Class Period”).
NEW YORK, NY / ACCESSWIRE / July 3, 2024 / If you suffered a loss on your Humana Inc. (NYSE:HUM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/humana-lawsuit-submission-form?prid=89052&wire=1 or contact Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / July 3, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Humana Inc. ("Humana" or "the Company") (NYSE:HUM) and certain of its officers. Class Definition: This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Humana securities between July 27, 2022 and January 24, 2024, inclusive (the "Class Period").
What type of business is Humana?
Humana, Inc. is a non-profit American medical insurance company (a diversified company in the healthcare system) founded in 1961. The headquarters is located in Louisville, Kentucky. The retail segment includes individual medical insurance, as well as individual commercial and special medical insurances, including dental, ophthalmological, and other additional healthcare services and financial protection. The group segment provides collective insurance services for employees and insurance for military personnel under a contract with the US Department of Defense. The healthcare segment includes autonomous enterprises that offer pharmaceutical supply services, provider services, and medical care services.
What sector is Humana in?
Humana is in the Healthcare sector
What industry is Humana in?
Humana is in the Healthcare Plans industry
What country is Humana from?
Humana is headquartered in United States
When did Humana go public?
Humana initial public offering (IPO) was on 31 December 1981
What is Humana website?
https://www.humana.com
Is Humana in the S&P 500?
Yes, Humana is included in the S&P 500 index
Is Humana in the NASDAQ 100?
No, Humana is not included in the NASDAQ 100 index
Is Humana in the Dow Jones?
No, Humana is not included in the Dow Jones index
When does Humana report earnings?
The next expected earnings date for Humana is 31 July 2024